In this interview with Tony Veverka, Chief Group Executive of BioEden, Mr. Veverka discusses how dental stem cells will impact our future. BioEden is a global stem cell storage company with laboratories in the UK and USA and sales operations in 19 countries. BioEden is also the world’s first international biobank company to collect, assess, and cryogenically store living stem cells from deciduous baby teeth.
Dental pulp is the soft living tissue inside a tooth that contains mesenchymal stem cells (MSCs). While MSCs from dental pulp stem cells are only being used only in laboratory settings right now, there are now a handful of forward-thinking companies that offer dental stem cell storage services to preserve the cells for future regenerative use.
The dental pulp storage market is still relatively small, because of the early stage of research concerning the use of dental pulp stem cells in humans. However, it is rapidly expanding on a global basis, with 1-2 new dental storage providers are entering the market every month, based on a trailing 12-month history (January to December, 2015).
BioEden began offering tooth stem cell storage as early as 2006, making it one of the earliest known providers of dental stem cell storage. Over the past decade, the company has continued to be one of the most dominant competitors in this space, controlling an estimated 45% of current market share within the dental stem cell storage market. Click here to learn more about the dental stem cell banking market or to read our recent interview with BioEden’s CEO, Tony Veverka. [Read more…]